Gut Microbiome and Colorectal Cancer
Gut Microbiome Dyspiosis in Colorectal Cancer Egyptian Patients
1 other identifier
observational
18
1 country
1
Brief Summary
Colorectal cancer (CRC) is reported to be the third leading cause of cancer deaths worldwide, and its prevalence is steadily rising in developing countries. It can be considered a marker of socioeconomic development and a marker of significant changes in food habits and lifestyle. In Egypt, CRC represents the seventh most common cancer. It is the third most reported cancer in males and the fifth most common cancer in females. microbiome dysbiosis may be involved in the pathogensis and thus pose a therapeutic target
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2024
CompletedFirst Submitted
Initial submission to the registry
December 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2024
CompletedFirst Posted
Study publicly available on registry
December 27, 2024
CompletedDecember 27, 2024
December 1, 2024
9 months
December 17, 2024
December 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The effect of food and lifestyle on microbiome
correlation between food and lifestyle with microbiome profiles
"through study completion, an average of 1 year"
microbiome profile and CRC pathogensis
correlation between microbiome profile and CRC pathogensis
"through study completion, an average of 1 year"
Study Arms (2)
contol group
6 healthy participants
CRC group
12 newly diagnosed CRC patients
Interventions
Eligibility Criteria
12 newly diagnosed CRC patiens vs 6 healthy voulnteers
You may qualify if:
- Age of 40 years to 80 years
- Patients with a newly diagnosed CRC
You may not qualify if:
- Patients with previously known CRC
- Pregnancy or Lactation
- Abdominal surgery within/up to 6 months prior to sample collection
- Antibiotics, corticosteroids, or probiotics up to three months prior to sample collection
- History of other types of cancer
- Subjects on a special diet
- Diabetes, liver, or kidney diseases
- CRC patients who used enema or underwent colonoscopy up to one week before sample collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
cairo university Hopitals (elKasr ELieny )
Cairo, Egypt
Related Publications (1)
Baas FS, Brusselaers N, Nagtegaal ID, Engstrand L, Boleij A. Navigating beyond associations: Opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis. Cell Host Microbe. 2024 Aug 14;32(8):1235-1247. doi: 10.1016/j.chom.2024.07.008.
PMID: 39146796BACKGROUND
Related Links
Biospecimen
DNA extracted from fecal samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
sara M eladwy
Heliopolis University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
December 17, 2024
First Posted
December 27, 2024
Study Start
January 1, 2024
Primary Completion
September 17, 2024
Study Completion
December 17, 2024
Last Updated
December 27, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Patients' information will be assigned codes. no need to reveal it